Rozance PJ, Limesand SW, Barry JS, Brown LD, Hay WW Jr
doi: 10.3390/insects12010032 391 ZhaoY.WangQ.ZhangY.ZhangP.JiangM
These are relatively mild compared to pharmaceutical GLP-1 medications, which commonly cause significant nausea, vomiting, diarrhea, constipation, and in rare cases more serious effects including pancreatitis and thyroid concerns
While these medications had impactful weight loss outcomes, with mean weight reduction in trials ranging from 7 to 10% [3,4,5], they lacked substantial evidence of improvement in cardiovascular outcomes
Growth hormone-stimulating peptides aren't appropriate for everyone
Compatibility with Routines: Easily fits into existing regimens, enhancing other products' effects